Is UC-MSC therapy for HFrEF available in China?

Yes. It is available through the Hainan Lecheng biomedical-technology access pathway at Hainan Haikong Le City Hospital. This pathway does not mean the therapy has nationwide approval in China.

How much does UC-MSC therapy for HFrEF cost in China?

The estimated cost is ¥60,000 (approximately US$8,900) per session. Three weekly sessions constitute one course, with an estimated treatment-course cost of ¥180,000 (approximately US$26,800). Confirm final pricing with the hospital.

Who may qualify for UC-MSC therapy for HFrEF?

The stated eligibility criteria are LVEF ≤40% and NYHA functional class II–IV. The attending physician also evaluates cardiac function, imaging, and overall clinical condition before determining eligibility.

How is umbilical cord-derived MSC therapy administered?

The treatment uses intravenous reinfusion of umbilical cord-derived mesenchymal stem cells. One course consists of three sessions administered once a week.

top of page

ChinaCurelink
a MedeboundHEALTH Company

FREE CONSULTATION

Human UC-MSC Therapy for HFrEF in China: A Guide for International Patients

ChinaCureLink

Tue Aug 25 2026

6 min read

Widget Didn’t Load

Check your internet and refresh this page.

If that doesn’t work, contact us.

bottom of page